Natalizumab is a
humanized monoclonal antibody against the
cellular adhesion molecule α4-integrin. Natalizumab is used in the treatment of
multiple sclerosis and
Crohn's disease. It is co-marketed by
Biogen Idec and
Élan as Tysabri, and was previously named Antegren....
No comments:
Post a Comment